Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Esteve

Showing results (171-180 of 223) with videos related to

Pageof 23
Sort By:
EMBO Molecular Medicine|June 13, 2022
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertibPiotr Kobialka, Helena Sabata, Odena Vilalta, et al.
Nature Communications|December 14, 2023
Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulationM C Martinez-Campanario, Marlies Cortés, Alazne Moreno-Lanceta, et al.
Cancers|September 23, 2022
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse SettingMargarita Romeo, Marta Gil-Martín, Lydia Gaba, et al.
The Journal of Pathology|June 14, 2024
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic nicheEster Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz, et al.
Cancers|April 26, 2025
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort StudyHelena Pla, Bartomeu Fullana, Anna Esteve, et al.
Cell Reports. Medicine|April 12, 2023
MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancerJuan J Alburquerque-Bejar, Pablo Navajas-Chocarro, Maria Saigi, et al.
Cancer Research|October 12, 2022
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast CancerSantiago Duro-Sánchez, Mercedes Nadal-Serrano, Marta Lalinde-Gutiérrez, et al.
Vaccines|May 25, 2024
Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2David Marín-Moraleda, Jordana Muñoz-Basagoiti, Aida Tort-Miró, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 4, 2023
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancerLucía Gutiérrez-Chamorro, Eudald Felip, Eva Castellà, et al.
Haematologica|March 13, 2025
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemiaDaniel Medina-Gil, Laura Palomo, Víctor Navarro, et al.
Pageof 23

Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
EMBO Molecular Medicine|June 13, 2022
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertibPiotr Kobialka, Helena Sabata, Odena Vilalta, et al.
Nature Communications|December 14, 2023
Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulationM C Martinez-Campanario, Marlies Cortés, Alazne Moreno-Lanceta, et al.
Cancers|September 23, 2022
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse SettingMargarita Romeo, Marta Gil-Martín, Lydia Gaba, et al.
The Journal of Pathology|June 14, 2024
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic nicheEster Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz, et al.
Cancers|April 26, 2025
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort StudyHelena Pla, Bartomeu Fullana, Anna Esteve, et al.
Cell Reports. Medicine|April 12, 2023
MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancerJuan J Alburquerque-Bejar, Pablo Navajas-Chocarro, Maria Saigi, et al.
Cancer Research|October 12, 2022
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast CancerSantiago Duro-Sánchez, Mercedes Nadal-Serrano, Marta Lalinde-Gutiérrez, et al.
Vaccines|May 25, 2024
Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2David Marín-Moraleda, Jordana Muñoz-Basagoiti, Aida Tort-Miró, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 4, 2023
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancerLucía Gutiérrez-Chamorro, Eudald Felip, Eva Castellà, et al.
Haematologica|March 13, 2025
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemiaDaniel Medina-Gil, Laura Palomo, Víctor Navarro, et al.
Pageof 23